ArticleAdvances in experimental medicine and biology2021

Toll-Like Receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective.

Ritwik Patra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.